Hemostasis in pre-eclampsia

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 2, 2011, Pages 111-117

  Khadijah Ismail, Siti ^a   Higgins, John R ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

coagulation; fibrinolysis; hemostasis; Pre eclampsia; pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR RISK; FIBRINOLYSIS; GENETIC DISORDER; HEMOSTASIS; HUMAN; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOPHILIA; UTERUS BLOOD FLOW;

ASPIRIN; FEMALE; HEMOSTASIS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PLACENTAL CIRCULATION; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; THROMBOPHILIA;

EID: 79952287463     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270336     Document Type: Article

References (59)

1. Roberts J M., Gammill H S. Preeclampsia: recent insights. Hypertension 2005 46 6 1243-1249 (Pubitemid 43189714)
2. Lain K Y., Roberts J M. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002 287 24 3183-3186 (Pubitemid 34686089)
3. Roberts J M., Lain K Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002 23 5 359-372 (Pubitemid 41110499)
4. Eichinger S, Weltermann A, Philipp K et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999 82 4 1232-1236 (Pubitemid 29473783)
5. Baglin T. The measurement and application of thrombin generation. Br J Haematol 2005 130 5 653-661 (Pubitemid 43906639)
6. Rosenkranz A, Hiden M, Leschnik B et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008 99 2 331-337 (Pubitemid 351230963)
7. Rafik Hamad R, Curvers J, Berntorp E, Eriksson M, Bremme K. Increased thrombin generation in women with a history of preeclampsia. Thromb Res 2009 123 4 580-586
8. Macey M G., Bevan S, Alam S et al. Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res 2010 125 3 e76-e81
9. Duley L, Henderson-Smart D J., Meher S, King J F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007 2 CD004659
10. Stirling Y, Woolf L, North W R., Seghatchian M J., Meade T W. Haemostasis in normal pregnancy. Thromb Haemost 1984 52 2 176-182 (Pubitemid 14024007)
11. Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981 12 3 141-154 (Pubitemid 11150978)
12. Wickström K, Edelstam G, Löwbeer C H., Hansson L O., Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004 64 1 31-40 (Pubitemid 38283207)
13. Tanjung M T., Siddik H D., Hariman H, Koh S C. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005 11 4 467-473 (Pubitemid 41546775)
14. Bonnar J, Redman C W., Denson K W. The role of coagulation and fibrinolysis in preeclampsia. Perspect Nephrol Hypertens 1976 5 85-93
15. Edstrom C S., Calhoun D A., Christensen R D. Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev 2000 59 2 77-84
16. Kisiel W, Sprecher C A., Foster D C. Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent. Blood 1994 84 12 4384-4385 (Pubitemid 24371947)
17. Chand H S., Foster D C., Kisiel W. Structure, function and biology of tissue factor pathway inhibitor-2. Thromb Haemost 2005 94 6 1122-1130 (Pubitemid 41819605)
18. Erez O, Romero R, Hoppensteadt D et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med 2008 21 12 855-869
19. Abdel Gader A M., Al-Mishari A A., Awadalla S A., Buyuomi N M., Khashoggi T, Al-Hakeem M. Total and free tissue factor pathway inhibitor in pregnancy hypertension. Int J Gynaecol Obstet 2006 95 3 248-253 (Pubitemid 44715902)
20. Oliver J J., Webb D J., Newby D E. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005 25 12 2470-2479 (Pubitemid 43732266)
21. Coolman M, de Groot C J., Steegers E A. et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 2006 128 1-2 22-28 (Pubitemid 44311352)
22. Robb A O., Mills N L., Din J N. et al. Acute endothelial tissue plasminogen activator release in pregnancy. J Thromb Haemost 2009 7 1 138-142
23. Reith A, Booth N A., Moore N R., Cruickshank D J., Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 1993 100 4 370-374 (Pubitemid 23121160)
24. Hunt B J., Missfelder-Lobos H, Parra-Cordero M et al. Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks. J Thromb Haemost 2009 7 6 955-961
25. Lockwood C J., Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 1999 17 1 45-51 (Pubitemid 29293552)
26. Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haematol 2003 16 2 183-195
27. Pijnenborg R, Robertson W B., Brosens I, Dixon G. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta 1981 2 1 71-91 (Pubitemid 11179363)
28. Lockwood C J., Krikun G, Runic R, Schwartz L B., Mesia A F., Schatz F. Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 2000 85 1 297-301 (Pubitemid 32268829)
29. Dusse L M., Carvalho M G., Cooper A J., Lwaleed B A. Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications? Clin Chim Acta 2006 372 1-2 43-46 (Pubitemid 44286764)
30. Lockwood C J., Krikun G, Caze R, Rahman M, Buchwalder L F., Schatz F. Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis. Ann N Y Acad Sci 2008 1127 67-72 (Pubitemid 351563106)
31. Chen J, Bierhaus A, Schiekofer S et al. Tissue factora receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001 86 1 334-345 (Pubitemid 32663964)
32. Parry G C., Mackman N. Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest 2000 105 11 1547-1554 (Pubitemid 30390305)
33. Pedersen B, Holscher T, Sato Y, Pawlinski R, Mackman N. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood 2005 105 7 2777-2782 (Pubitemid 40446269)
34. Isermann B, Hendrickson S B., Hutley K, Wing M, Weiler H. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 2001 128 6 827-838 (Pubitemid 32288194)
35. Estellés A, Gilabert J, Grancha S et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998 79 3 500-508 (Pubitemid 28120779)
36. Aharon A, Lanir N, Drugan A, Brenner B. Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. J Thromb Haemost 2005 3 10 2355-2357 (Pubitemid 41727221)
37. Ogawa M, Yanoma S, Nagashima Y et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta 2007 28 2-3 224-232 (Pubitemid 44914519)
38. Fazel A, Vincenot A, Malassiné A et al. Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli. Placenta 1998 19 4 261-268 (Pubitemid 28224794)
39. Estellés A, Gilabert J, Keeton M et al. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 1994 84 1 143-150 (Pubitemid 24193815)
40. Higgins J R., Walshe J J., Darling M R., Norris L, Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998 179 2 520-526 (Pubitemid 28413394)
41. Kupferminc M J., Eldor A, Steinman N et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999 340 1 9-13 (Pubitemid 29024678)
42. Robertson L, Wu O, Langhorne P et al. Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006 132 2 171-196
43. Said J M., Higgins J R., Moses E K. et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010 115 1 5-13
44. Silver R M., Zhao Y, Spong C Y. et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (NICHD MFMU) Network. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010 115 1 14-20
45. Many A, Schreiber L, Rosner S, Lessing J B., Eldor A, Kupferminc M J. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001 98 6 1041-1044 (Pubitemid 34075328)
46. Mousa H A., Alfirevic Z I. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000 15 8 1830-1833 (Pubitemid 30636078)
47. Greer I A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005 106 2 401-407 (Pubitemid 40981229)
48. Pabinger I, Grafenhofer H, Kaider A et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001 21 5 874-879 (Pubitemid 32448783)
49. Alguel G, Vormittag R, Simanek R et al. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy. Thromb Haemost 2006 96 3 285-289 (Pubitemid 44377810)
50. Rey E, Garneau P, David M et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009 7 1 58-64
51. Riyazi N, Leeda M, de Vries J I., Huijgens P C., van Geijn H P., Dekker G A. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998 80 1 49-54 (Pubitemid 29272019)
52. Kupferminc M J., Fait G, Many A et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001 20 1 35-44 (Pubitemid 32672926)
53. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994 343 8898 619-629
54. Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2009 146 1 46-49
55. Thornton C A., Bonnar J. Factor VIII-related antigen and factor VIII coagulant activity in normal and pre-eclamptic pregnancy. Br J Obstet Gynaecol 1977 84 12 919-923 (Pubitemid 8251574)
56. Bonnar J, McNicol G P., Douglas A S. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. BMJ 1971 2 5752 12-16
57. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994 101 6 488-492 (Pubitemid 24210148)
58. Chaiworapongsa T, Yoshimatsu J, Espinoza J et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002 11 6 362-367 (Pubitemid 34836885)
59. Bellart J, Gilabert R, Anglès A et al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999 106 6 594-597 (Pubitemid 29245593)